GGrantIndex
← Search

Phase I Clinical Trial Unit for Therapeutics

$914,213N01FY2014AINIH

Dynport Vaccine Company, Llc, Frederick MD

Investigators

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic agents for the treatment of infectious disease.

View original record on NIH RePORTER →
Phase I Clinical Trial Unit for Therapeutics · GrantIndex